Inhibition of Raf Kinase Using Substituted Heterocyclic Ureas

Details for Australian Patent Application No. 2008252068 (hide)

Owner Bayer Healthcare LLC

Inventors Johnson, Jeffrey; Lowinger, Timothy Bruno; Scott, William J.; Wood, Jill E.; Khire, Uday; Redman, Aniko; HatoumMokdad, Holia; Smith, Roger A.; Riedl, Bernd; Paulsen, Holger; Dumas, Jacques; Lee, Wendy

Agent Cullens

Pub. Number AU-B-2008252068

Parent 2006201959

Filing date 4 December 2008

Wipo publication date 8 January 2009

Acceptance publication date 3 February 2011

International Classifications

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/38 (2006.01) - having sulfur as a ring hetero atom

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/425 (2006.01) - Thiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/47 (2006.01) - Quinolines

C07D 231/40 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 257/06 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 261/14 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 263/48 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 271/113 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

C07D 277/28 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/135 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 307/66 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/36 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

18 December 2008 Complete Application Filed

8 January 2009 Application Open to Public Inspection

  Published as AU-B-2008252068

13 August 2009 Assignment before Grant

  Bayer Corporation The application has been assigned to Bayer Healthcare LLC

3 February 2011 Application Accepted

  Published as AU-B-2008252068

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008252069-Reinforced glitter

2008252067-Advertising method and system